/ WHO WE ARE
RiverVest is a leading venture capital firm building life science companies to address significant unmet medical needs.
8
FUNDS
Since 2000
/ EXPERT INSIGHT
Glycosylation is crucial to the development of healthy organs and tissues. Could replacing a missing sugar help patients with a rare glycosylation disorder improve coordination and mobility?
/ EXPERT INSIGHT
Diabetes Treatment: A Story of Complicated Progress and Great Potential
RiverVest Managing Director Derek Rapp discusses the global health threat of diabetes and shares his thoughts on the innovation ecosystem that is essential to achieving better outcomes for patients.
/ EXPERT INSIGHT
Learn how Alleviant’s no-implant approach addresses the full spectrum of chronic heart failure.
30
COMMERCIAL PRODUCTS
Currently Treating Patients
RiverVest strives to improve the lives of patients, support entrepreneurs, and earn the trust of investors through science, strategy, and innovation.
Contact us at info@rivervest.com
Transparency in Coverage Rule: To access the machine-readable files created and published by United Healthcare, please click here.
© Copyright 2025 RiverVest® All Rights Reserved. | Privacy Policy
Subscribe to our newsletter